|
|
Article: Asterand Announces Collaborative Agreement to Characterise Antibodies.
- Article from:
- Biotech Week
- Article date:
- May 13, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Asterand plc (LSE:ATD), a leading provider of human tissue and services to scientists engaged in drug discovery research, announces that it has entered into a collaborative agreement with Abcam plc (AIM:ABC), the rapidly growing bioscience company that markets antibodies via its own online catalogue. Asterand will undertake the validation and characterisation of a selected group of Abcam antibodies for immuno-histochemistry applications using Asterand's PhaseZERO® Human Tissue Services platform (see also Asterand plc).
Through this agreement, Asterand will utilise its proprietary Target Evaluator™ database to pinpoint the expression patterns of ...